Inhibition of the Type III Epidermal Growth Factor Receptor Variant Mutant Receptor by Dominant-Negative EGFR-CD533 Enhances Malignant Glioma Cell Radiosensitivity

by G. Lammering

Published in Clinical Cancer Research by American Association for Cancer Research (AACR).

2004 Volume 10, Issue 19, p6732-6743

application/pdf 521.0 kB `file_l4jimxbtwbbg7izwkm5p43gtbq`
application/pdf 463.2 kB `file_titnmriuofehxgpfutbvkdt5di`	clincancerres.aacrjournals.org (web) web.archive.org (webarchive)
application/pdf 547.3 kB `file_dinqfviszbg3zeqtyt54u5diiu`	web.archive.org (webarchive) clincancerres.aacrjournals.org (web)
application/pdf 547.3 kB `file_nj6inho6ozccddsrth36hvuba4`	web.archive.org (webarchive) clincancerres.aacrjournals.org (web)

Preserved and Accessible

Type article-journal
Stage

published

Date 2004-10-01
Language en ^?

DOI 10.1158/1078-0432.ccr-04-0393
PubMed 15475464
Wikidata Q40505726

Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L: 1078-0432

Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)

Cite This

BibTeX
CSL-JSON
MLA
Harvard

Lookup Links

oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar

Catalog Record
Revision: e0a2a2f5-842e-40bd-8320-b500c0b0237e
API URL: JSON

Inhibition of the Type III Epidermal Growth Factor Receptor Variant Mutant Receptor by Dominant-Negative EGFR-CD533 Enhances Malignant Glioma Cell Radiosensitivity release_hubei5ggnfhtfp5leqb6tlgdvq